Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 14
2017 34
2018 17
2019 8
2020 5
2021 4
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 29123012

77 results

Results by year

Filters applied: . Clear all
Page 1
Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2).
Seifert R, Emmett L, Rowe SP, Herrmann K, Hadaschik B, Calais J, Giesel FL, Reiter R, Maurer T, Heck M, Gafita A, Morris MJ, Fanti S, Weber WA, Hope TA, Hofman MS, Fendler WP, Eiber M. Seifert R, et al. Eur Urol. 2023 May;83(5):405-412. doi: 10.1016/j.eururo.2023.02.002. Epub 2023 Mar 17. Eur Urol. 2023. PMID: 36935345 Free article. Review.
PSMA Ligands for PET Imaging of Prostate Cancer.
Schwarzenboeck SM, Rauscher I, Bluemel C, Fendler WP, Rowe SP, Pomper MG, Afshar-Oromieh A, Herrmann K, Eiber M. Schwarzenboeck SM, et al. J Nucl Med. 2017 Oct;58(10):1545-1552. doi: 10.2967/jnumed.117.191031. Epub 2017 Jul 7. J Nucl Med. 2017. PMID: 28687599 Free article. Review.
PSMA PET and Radionuclide Therapy in Prostate Cancer.
Bouchelouche K, Turkbey B, Choyke PL. Bouchelouche K, et al. Semin Nucl Med. 2016 Nov;46(6):522-535. doi: 10.1053/j.semnuclmed.2016.07.006. Epub 2016 Sep 3. Semin Nucl Med. 2016. PMID: 27825432 Free PMC article. Review.
Comparison of standard and delayed imaging to improve the detection rate of [68Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancer.
Schmuck S, Nordlohne S, von Klot CA, Henkenberens C, Sohns JM, Christiansen H, Wester HJ, Ross TL, Bengel FM, Derlin T. Schmuck S, et al. Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):960-968. doi: 10.1007/s00259-017-3669-5. Epub 2017 Mar 9. Eur J Nucl Med Mol Imaging. 2017. PMID: 28280856
77 results